GlassScriptPhysician profile
Aaron C Roberts
NPI 1891088753
$31,102.75
in general payments reported to CMS, 2019-2025
13 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 81% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $1,281 · 2021: $6,348 · 2022: $11K · 2023: $1,296 · 2024: $9,837 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,336 · Food and Beverage: $3,948 · Travel and Lodging: $882 · Consulting Fee: $350 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,336.00 |
| Food and Beverage | $3,947.99 |
| Travel and Lodging | $881.72 |
| Consulting Fee | $350.00 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $17,025.32 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $10,025.05 | 2019-2025 | Xywav |
| Inspire Medical Systems, INC. | $3,032.45 | 2020-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $420.62 | 2024-2025 | Lumryz |
| Zoll Respicardia, INC. | $155.52 | 2024 | Remede System |
| Eisai INC. | $124.25 | 2022 | |
| Idorsia Pharmaceuticals US INC | $121.85 | 2022 | |
| Axsome Therapeutics, INC. | $67.13 | 2023-2025 | Sunosi |
| Fisher & Paykel Healthcare INC | $57.89 | 2022-2024 | Fisher & Paykel Healthcare |
| Itamar Medical INC | $23.22 | 2024 | Watchpatone |
| Janssen Pharmaceuticals, INC | $22.91 | 2022 | |
| Merck Sharp & Dohme LLC | $13.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.